Additionally, we showed that plasma levels of CRP, SAA1, and SAA2 are different six months after COVID-19 recovery in patients in whom changes in left ventricular mass and geometry were detected in acute disease and follow-up, compared to those who did not show significant changes in cardiac structure and function (Fig. 5B). This evidence concerns the gene CRP and COVID-19.